"World's Most Complete Market Research Reports Repository"

Global Anti-Infective Drugs Market Insights, Forecast to 2025

This report studies the global market size of Anti-Infective Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-Infective Drugs in these regions.
This research report categorizes the global Anti-Infective Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Anti-Infective Drugs market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Anti-Infective Drugs market based on company, product type, application and key regions.

The various contributors involved in the value chain of Anti-Infective Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Anti-Infective Drugs include
GlaxoSmithKline
Merck
Pfizer
Novartis AG
Gilead Sciences
Abbott
Wyeth
Sanofi-Aventis
Bristol-Myers Squibb
Johnson
Roche Pharma AG
Nanosphere
NanoViricides
Novabay Pharmaceuticals
Obetech
Optimer Pharmaceuticals
Basilea Pharmaceutica AG
Daiichi Sankyo
MerLion Pharma
Theravance

Market Size Split by Type
Antibiotic Drugs
Antiviral Drugs
Antifungal Drugs
Other
Market Size Split by Application
Hospital
Clinic
Home
Other

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Anti-Infective Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Anti-Infective Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Anti-Infective Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anti-Infective Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Anti-Infective Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Anti-Infective Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-Infective Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Anti-Infective Drugs Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Anti-Infective Drugs Market Size Growth Rate by Type
1.4.2 Antibiotic Drugs
1.4.3 Antiviral Drugs
1.4.4 Antifungal Drugs
1.4.5 Other
1.5 Market by Application
1.5.1 Global Anti-Infective Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Home
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Anti-Infective Drugs Market Size
2.1.1 Global Anti-Infective Drugs Revenue 2016-2025
2.1.2 Global Anti-Infective Drugs Sales 2016-2025
2.2 Anti-Infective Drugs Growth Rate by Regions
2.2.1 Global Anti-Infective Drugs Sales by Regions
2.2.2 Global Anti-Infective Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Anti-Infective Drugs Sales by Manufacturers
3.1.1 Anti-Infective Drugs Sales by Manufacturers
3.1.2 Anti-Infective Drugs Sales Market Share by Manufacturers
3.1.3 Global Anti-Infective Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Anti-Infective Drugs Revenue by Manufacturers
3.2.1 Anti-Infective Drugs Revenue by Manufacturers (2016-2018)
3.2.2 Anti-Infective Drugs Revenue Share by Manufacturers (2016-2018)
3.3 Anti-Infective Drugs Price by Manufacturers
3.4 Anti-Infective Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anti-Infective Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Infective Drugs Product Category
3.4.3 Date of International Manufacturers Enter into Anti-Infective Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Anti-Infective Drugs Sales by Type
4.2 Global Anti-Infective Drugs Revenue by Type
4.3 Anti-Infective Drugs Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Anti-Infective Drugs Breakdown Data by Application

6 North America
6.1 North America Anti-Infective Drugs by Countries
6.1.1 North America Anti-Infective Drugs Sales by Countries
6.1.2 North America Anti-Infective Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Anti-Infective Drugs by Type
6.3 North America Anti-Infective Drugs by Application
6.4 North America Anti-Infective Drugs by Company

7 Europe
7.1 Europe Anti-Infective Drugs by Countries
7.1.1 Europe Anti-Infective Drugs Sales by Countries
7.1.2 Europe Anti-Infective Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Infective Drugs by Type
7.3 Europe Anti-Infective Drugs by Application
7.4 Europe Anti-Infective Drugs by Company

8 Asia Pacific
8.1 Asia Pacific Anti-Infective Drugs by Countries
8.1.1 Asia Pacific Anti-Infective Drugs Sales by Countries
8.1.2 Asia Pacific Anti-Infective Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Anti-Infective Drugs by Type
8.3 Asia Pacific Anti-Infective Drugs by Application
8.4 Asia Pacific Anti-Infective Drugs by Company

9 Central & South America
9.1 Central & South America Anti-Infective Drugs by Countries
9.1.1 Central & South America Anti-Infective Drugs Sales by Countries
9.1.2 Central & South America Anti-Infective Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Anti-Infective Drugs by Type
9.3 Central & South America Anti-Infective Drugs by Application
9.4 Central & South America Anti-Infective Drugs by Company

10 Middle East and Africa
10.1 Middle East and Africa Anti-Infective Drugs by Countries
10.1.1 Middle East and Africa Anti-Infective Drugs Sales by Countries
10.1.2 Middle East and Africa Anti-Infective Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Anti-Infective Drugs by Type
10.3 Middle East and Africa Anti-Infective Drugs by Application
10.4 Middle East and Africa Anti-Infective Drugs by Company

11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Anti-Infective Drugs
11.1.4 Anti-Infective Drugs Product Description
11.1.5 Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Anti-Infective Drugs
11.2.4 Anti-Infective Drugs Product Description
11.2.5 Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Anti-Infective Drugs
11.3.4 Anti-Infective Drugs Product Description
11.3.5 Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Anti-Infective Drugs
11.4.4 Anti-Infective Drugs Product Description
11.4.5 Recent Development
11.5 Gilead Sciences
11.5.1 Gilead Sciences Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Anti-Infective Drugs
11.5.4 Anti-Infective Drugs Product Description
11.5.5 Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Anti-Infective Drugs
11.6.4 Anti-Infective Drugs Product Description
11.6.5 Recent Development
11.7 Wyeth
11.7.1 Wyeth Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Anti-Infective Drugs
11.7.4 Anti-Infective Drugs Product Description
11.7.5 Recent Development
11.8 Sanofi-Aventis
11.8.1 Sanofi-Aventis Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Anti-Infective Drugs
11.8.4 Anti-Infective Drugs Product Description
11.8.5 Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Anti-Infective Drugs
11.9.4 Anti-Infective Drugs Product Description
11.9.5 Recent Development
11.10 Johnson
11.10.1 Johnson Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Anti-Infective Drugs
11.10.4 Anti-Infective Drugs Product Description
11.10.5 Recent Development
11.11 Roche Pharma AG
11.12 Nanosphere
11.13 NanoViricides
11.14 Novabay Pharmaceuticals
11.15 Obetech
11.16 Optimer Pharmaceuticals
11.17 Basilea Pharmaceutica AG
11.18 Daiichi Sankyo
11.19 MerLion Pharma
11.20 Theravance

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Anti-Infective Drugs Raw Material
13.1.2 Anti-Infective Drugs Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Picture of Anti-Infective Drugs
Figure Global Anti-Infective Drugs Production (K MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Anti-Infective Drugs Production Market Share by Types (Product Category) in 2017
Figure Antibiotic Drugs Product Picture
Table Major Manufacturers of Antibiotic Drugs
Figure Antiviral Drugs Product Picture
Table Major Manufacturers of Antiviral Drugs
Figure Antifungal Drugs Product Picture
Table Major Manufacturers of Antifungal Drugs
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Anti-Infective Drugs Market Size Growth Rate by Application 2018-2025 (K MT)
Figure Hospital
Figure Clinic
Figure Home
Figure Other
Figure Anti-Infective Drugs Report Years Considered
Figure Global Anti-Infective Drugs Market Size 2016-2025 (Million US$)
Figure Global Anti-Infective Drugs Sales 2016-2025 (K MT)
Table Global Anti-Infective Drugs Market Size by Regions 2016-2025 (K MT) & (Million US$)
Table Global Anti-Infective Drugs Sales by Regions 2016-2025 (K MT)
Table Global Anti-Infective Drugs Sales Market Share by Regions 2016-2025
Figure Global Anti-Infective Drugs Sales Market Share by Regions 2016-2025
Figure 2017 Global Anti-Infective Drugs Sales Market Share by Regions
Table Global Anti-Infective Drugs Revenue by Regions 2016-2025 (Million US$)
Table Global Anti-Infective Drugs Revenue Market Share by Regions 2016-2025
Figure Global Anti-Infective Drugs Revenue Market Share by Regions 2016-2025
Figure 2017 Global Anti-Infective Drugs Revenue Market Share by Regions
Table Global Anti-Infective Drugs Sales by Manufacturers (2016-2018) (K MT)
Table Global Anti-Infective Drugs Sales Share by Manufacturers (2016-2018)
Figure Global Anti-Infective Drugs Sales Share by Manufacturers in 2017
Table Anti-Infective Drugs Revenue by Manufacturers (2016-2018) (Million US$)
Table Anti-Infective Drugs Revenue Share by Manufacturers (2016-2018)
Figure Anti-Infective Drugs Value Share by Manufacturers in 2017
Table Global Anti-Infective Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Anti-Infective Drugs Price (2016-2018) (USD/MT)
Table Anti-Infective Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Anti-Infective Drugs Product Category
Table Date of International Manufacturers Enter into Anti-Infective Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Anti-Infective Drugs Sales by Type (2016-2025) (K MT)
Table Global Anti-Infective Drugs Sales Share by Type (2016-2025)
Figure Global Anti-Infective Drugs Sales Market Share by Type (2016-2025)
Figure Global Anti-Infective Drugs Sales Market Share by Type in 2017
Table Global Anti-Infective Drugs Revenue by Type (2016-2025) (Million US$)
Table Global Anti-Infective Drugs Revenue Share by Type (2016-2025)
Figure Global Anti-Infective Drugs Revenue Market Share by Type (2016-2025)
Figure Global Anti-Infective Drugs Revenue Market Share by Type in 2017
Table Anti-Infective Drugs Price by Type 2013-2018 (USD/MT)
Table Global Anti-Infective Drugs Sales by Application (2016-2025) (K MT)
Table Global Anti-Infective Drugs Sales Share by Application (2016-2025)
Figure Global Sales Anti-Infective Drugs Market Share by Application (2016-2025)
Figure Global Sales Anti-Infective Drugs Market Share by Application (2016-2025)
Figure North America Anti-Infective Drugs Sales Growth Rate 2016-2025 (K MT)
Figure North America Anti-Infective Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table North America Anti-Infective Drugs Sales by Countries (2016-2025) (K MT)
Table North America Anti-Infective Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 North America Anti-Infective Drugs Sales Market Share by Countries
Table North America Anti-Infective Drugs Revenue by Countries (2016-2025) (Million US$)
Table North America Anti-Infective Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Anti-Infective Drugs Revenue Market Share by Countries
Figure United States Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure United States Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure Canada Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure Mexico Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table North America Anti-Infective Drugs Sales by Type (2016-2025) (K MT)
Table North America Anti-Infective Drugs Sales Market Share by Type (2016-2025)
Figure 2017 North America Anti-Infective Drugs Market Share by Type
Table North America Anti-Infective Drugs Sales by Application (2016-2025) (K MT)
Table North America Anti-Infective Drugs Sales Market Share by Application (2016-2025)
Figure 2017 North America Anti-Infective Drugs Market Share by Application
Table North America Anti-Infective Drugs Sales by Company (2016-2018) (K MT)
Table North America Anti-Infective Drugs Sales Market Share by Company (2016-2018)
Figure North America Anti-Infective Drugs Sales Market Share by Company in 2017
Figure Europe Anti-Infective Drugs Sales Growth Rate 2016-2025 (K MT)
Figure Europe Anti-Infective Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Anti-Infective Drugs Sales by Countries (2016-2025) (K MT)
Table Europe Anti-Infective Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Anti-Infective Drugs Sales Market Share by Countries
Table Europe Anti-Infective Drugs Revenue by Countries (2016-2025) (Million US$)
Table Europe Anti-Infective Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Anti-Infective Drugs Revenue Market Share by Countries
Figure Germany Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure Germany Anti-Infective Drugs Revenue Growth Rate (2016-2025) (K MT)
Figure France Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure France Anti-Infective Drugs Revenue Growth Rate (2016-2025) (K MT)
Figure UK Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure UK Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure Italy Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure Russia Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Anti-Infective Drugs Sales by Type (2016-2025) (K MT)
Table Europe Anti-Infective Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Europe Anti-Infective Drugs Market Share by Type
Table Europe Anti-Infective Drugs Sales by Application (2016-2025) (K MT)
Table Europe Anti-Infective Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Europe Anti-Infective Drugs Market Share by Application
Table Europe Anti-Infective Drugs Sales by Company (2016-2018) (K MT)
Table Europe Anti-Infective Drugs Sales Market Share by Company (2016-2018)
Figure Europe Anti-Infective Drugs Sales Market Share by Company in 2017
Figure Asia Pacific Anti-Infective Drugs Sales Growth Rate 2016-2025 (K MT)
Figure Asia Pacific Anti-Infective Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Anti-Infective Drugs Sales by Countries (2016-2025) (K MT)
Table Asia Pacific Anti-Infective Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Anti-Infective Drugs Sales Market Share by Countries
Table Asia Pacific Anti-Infective Drugs Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Anti-Infective Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Anti-Infective Drugs Revenue Market Share by Countries
Figure China Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure China Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure Japan Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure Korea Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure India Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure India Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure Australia Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure Indonesia Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure Malaysia Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure Philippines Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure Thailand Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure Vietnam Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure Singapore Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Anti-Infective Drugs Sales by Type (2016-2025) (K MT)
Table Asia Pacific Anti-Infective Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Anti-Infective Drugs Market Share by Type
Table Asia Pacific Anti-Infective Drugs Sales by Application (2016-2025) (K MT)
Table Asia Pacific Anti-Infective Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Anti-Infective Drugs Market Share by Application
Table Asia Pacific Anti-Infective Drugs Sales by Company (2016-2018) (K MT)
Table Asia Pacific Anti-Infective Drugs Sales Market Share by Company (2016-2018)
Figure Asia Pacific Anti-Infective Drugs Sales Market Share by Company in 2017
Figure Central & South America Anti-Infective Drugs Sales Growth Rate 2016-2025 (K MT)
Figure Central & South America Anti-Infective Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Anti-Infective Drugs Sales by Countries (2016-2025) (K MT)
Table Central & South America Anti-Infective Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Anti-Infective Drugs Sales Market Share by Countries
Table Central & South America Anti-Infective Drugs Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Anti-Infective Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Anti-Infective Drugs Revenue Market Share by Countries
Figure Brazil Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure Brazil Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure Argentina Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Anti-Infective Drugs Sales by Type (2016-2025) (K MT)
Table Central & South America Anti-Infective Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Anti-Infective Drugs Market Share by Type
Table Central & South America Anti-Infective Drugs Sales by Application (2016-2025) (K MT)
Table Central & South America Anti-Infective Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Anti-Infective Drugs Market Share by Application
Table Central & South America Anti-Infective Drugs Sales by Company (2016-2018) (K MT)
Table Central & South America Anti-Infective Drugs Sales Market Share by Company (2016-2018)
Figure Central & South America Anti-Infective Drugs Sales Market Share by Company in 2017
Figure Middle East and Africa Anti-Infective Drugs Sales Growth Rate 2016-2025 (K MT)
Figure Middle East and Africa Anti-Infective Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Anti-Infective Drugs Sales by Countries (2016-2025) (K MT)
Table Middle East and Africa Anti-Infective Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Anti-Infective Drugs Sales Market Share by Countries
Table Middle East and Africa Anti-Infective Drugs Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Anti-Infective Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Anti-Infective Drugs Revenue Market Share by Countries
Figure GCC Countries Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure GCC Countries Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure Turkey Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure Egypt Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Anti-Infective Drugs Sales Growth Rate (2016-2025) (K MT)
Figure South Africa Anti-Infective Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Anti-Infective Drugs Sales by Type (2016-2025) (K MT)
Table Middle East and Africa Anti-Infective Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Anti-Infective Drugs Market Share by Type
Table Middle East and Africa Anti-Infective Drugs Sales by Application (2016-2025) (K MT)
Table Middle East and Africa Anti-Infective Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Anti-Infective Drugs Market Share by Application
Table Middle East and Africa Anti-Infective Drugs Sales by Company (2016-2018) (K MT)
Table Middle East and Africa Anti-Infective Drugs Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Anti-Infective Drugs Sales Market Share by Company in 2017
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Anti-Infective Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Anti-Infective Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Anti-Infective Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Novartis AG Company Details
Table Novartis AG Anti-Infective Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Novartis AG Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Anti-Infective Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Gilead Sciences Recent Development
Table Abbott Company Details
Table Abbott Anti-Infective Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Abbott Recent Development
Table Wyeth Company Details
Table Wyeth Anti-Infective Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Wyeth Recent Development
Table Sanofi-Aventis Company Details
Table Sanofi-Aventis Anti-Infective Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Sanofi-Aventis Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Anti-Infective Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Bristol-Myers Squibb Recent Development
Table Johnson Company Details
Table Johnson Anti-Infective Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Johnson Recent Development
Table Roche Pharma AG Company Details
Table Nanosphere Company Details
Table NanoViricides Company Details
Table Novabay Pharmaceuticals Company Details
Table Obetech Company Details
Table Optimer Pharmaceuticals Company Details
Table Basilea Pharmaceutica AG Company Details
Table Daiichi Sankyo Company Details
Table MerLion Pharma Company Details
Table Theravance Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Anti-Infective Drugs Value Chain
Table Typical Suppliers of Key Anti-Infective Drugs Raw Material
Table Anti-Infective Drugs Customers List
Table Anti-Infective Drugs Sales Channels
Table Anti-Infective Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Choose License Type